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*Mycobacterium chimaera* is a nontuberculous mycobacterium (NTM) species within the *Mycobacterium avium* complex (MAC). *M. chimaera* is an emerging cause of infection, in particular due to increasing awareness of infections linked with exposure to contaminated LivaNova Sorin Stockert 3T heater-cooler unit (HCU) devices ([@B1][@B2][@B12]). Despite the public health relevance of *M. chimaera*, no publicly available genome is representative of genotypes implicated in HCU contamination ([@B13], [@B14]). We present this here, using CDC2015-22-71, a clinical isolate from a Pennsylvania patient epidemiologically linked to a cluster of *M. chimaera* infections following exposure to an HCU.

Genomic DNA was extracted from CDC2015-22-71 grown in 7H9 broth (BD, Franklin Lakes, NJ, USA) at 36°C for approximately 1 week. The genome was sequenced using the Pacific Biosciences RSII (PacBio, Menlo Park, CA, USA) and Illumina MiSeq (San Diego, CA, USA) platforms. A 10-kb library was generated with the SMRTbell template prep kit 1. The library was then bound to polymerase using the DNA/polymerase binding kit P6v2. The bound library was loaded on two SMRTcells and sequenced with C4v2 chemistry for 360-min movies on the RSII instrument. Sequence reads were filtered and assembled *de novo* utilizing the PacBio HGAP version 3 ([@B15]). The PacBio assembly was corrected with Illumina reads using Pilon version 1.20 ([@B16]). The resulting assembly was compared to other *M. chimaera* genomes using Mauve version 2.3.1 ([@B17]). Genomic features were identified and annotated using the NCBI Prokaryotic Genome Annotation Pipeline.

The genome of *M. chimaera* CDC2015-22-71 consists of four scaffolds, equaling 6,247,640 bp (6,078,351-bp chromosome; 97,267-bp plasmid; 39,887-bp plasmid; 32,135-bp plasmid) and a G+C content of 67.6%. A total of 5,795 coding sequences were predicted, including 5,627 protein-coding genes and 168 pseudogenes. Our genome assembly contains 47 tRNAs, 3 noncoding RNAs, and 1 rRNA cistron consisting of the 16S, 23S, and 5S rRNA genes.

Whole-genome alignments of *M. chimaera* CDC2015-22-71, Hawaiian respiratory strain AH16 (GenBank accession number CP012885 \[[@B13]\]), and Irish respiratory strains MCIMRL6, MCIMRL4, and MCIMRL2 (GenBank accession numbers LJHN00000000, LJHM00000000, and LJHL00000000 \[[@B14]\]) revealed 15,077 single-nucleotide polymorphisms (SNPs) compared to AH16; 8,870 SNPs compared to MCIMRL2; 2,229 SNPs compared to MCIMRL4; and 8,098 SNPs compared to MCIMRL6. Comparison of gene content between the five *M. chimaera* genomes revealed a core gene set of 4,726 genes (83.9% of the 2015-22-71 genome \[[@B18]\]). The comparison of CDC2015-22-71 against all previously identified *M. chimaera* genomes resulted in average nucleotide identity values greater than or equal to 98.70%, which are greater than the 95 to 96% cutoff for species boundaries ([@B19]).

This *M. chimaera* genome assembly is the first complete NTM genome associated with an outbreak and will serve as a reference for epidemiological investigations of North American-based HCU contamination and postsurgical *M. chimaera* infections.
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The genome sequence of *M. chimaera* CDC2015-22-71 has been deposited in NCBI GenBank under accession numbers [CP019221](https://www.ncbi.nlm.nih.gov/nuccore/CP019221) through [CP019224](https://www.ncbi.nlm.nih.gov/nuccore/CP019224). PacBio and Illumina reads have been deposited in NCBI under BioProject number PRJNA344472 and BioSample number SAMN05824346.
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